/
/
The HealthTree® Foundation Unveils the First and Only Clinical Trial Finder Tool Designed Specifically for Acute Myeloid Leukemia (AML) Patients
The HealthTree® Foundation Unveils the First and Only Clinical Trial Finder Tool Designed Specifically for Acute Myeloid Leukemia (AML) Patients
Posted Sep 17, 2021

SALT LAKE CITY, Aug. 24, 2021 /PRNewswire/ -- The HealthTree® Foundation, a patient-driven, 501(c)(3) non-profit organization that empowers patients at each step of their disease journey, announced the launch of its clinical trial finder for acute myeloid leukemia (AML). Using the tool, AML patients can filter their clinical trial search - personalizing, simplifying, and accelerating the enrollment process.

This marks the latest update to the AML division of HealthTree as the foundation continues to expand its scope beyond multiple myeloma to other terminal illnesses and further its mission of increasing patient and researcher access to tools to navigate disease and aggregate data to accelerate cures.

"Patients tend to view clinical trials as a last resort," said Jenny Ahlstrom, founder of the HealthTree Foundation. "In reality, getting into clinical trials early can improve a patient's care trajectory, make new treatments available sooner, and potentially unlock new avenues of research toward a cure. There is a tremendous amount of research happening in acute myeloid leukemia right now and we want to make sure that the right information is being made available to patients."

The HealthTree for AML clinical trial tool consists of a continually updated list of clinical trials specific to AML, simplifying the search and enrollment process for patients. Patients can target their search through the use of more than 50 different advanced filters including patient age, trial phase and enrollment status, therapy type, and even the genetic target being studied; if a patient knows their cancer's particular mutation, they can find trials that are targeting that mutation specifically.

HealthTree has a dedicated team available by phone or email to help patients navigate the enrollment process and answer any specific questions. In the near future, the tool will become more personalized, showing only clinical trials that each individual patient is eligible to join, narrowing the search and further personalizing treatment options. Additional HealthTree software tools for AML patients such as a patient data portal, a virtual events platform and an AML "university" will soon follow.

"This AML specific clinical trial finder gives patients much needed direction and narrows down the monumental task of sifting through what could be hundreds of open trials to find the right options for their cancer's genetic makeup," said Katie Braswell, HealthTree for AML Community Director. "Finding, choosing, and enrolling in a trial can be a complicated, overwhelming process. We want to simplify the process, so patients feel equipped and empowered."

HealthTree Foundation resources are free to all AML patients.

Click to view the AML clinical trial finder

About The HealthTree Foundation

The HealthTree Foundation is a patient-driven, 501(c)(3) non-profit organization that empowers patients at each step of their disease journey. Blood cancer patients including AML and multiple myeloma can access the foundation's resources for free. Jennifer Ahlstrom and her husband Paul founded the HealthTree Foundation which provides patient education, advocacy and research funding for people with blood cancers.

The author Jenny Ahlstrom

about the author
Jenny Ahlstrom

Multiple myeloma patient, sister-in-law to AML patient, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by joining their disease communities and contributing their patient stories to advance a cure. Founder of the HealthTree Foundation. 

More HealthTree for AML Newsroom Articles

Article Image HealthTree Foundation wants to ease, demystify the clinical trial process for AML patients Article Image HealthTree® Foundation Announces the Launch of "HealthTree for Acute Myeloid Leukemia" (AML)

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Follow Us

facebook instagram twitter youtube

 

Terms of Use and Privacy Policy     Newsroom     About    Donations    Find an AML Specialist     Newsletter     Learn     Connect

 

Copyright © 2021 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811